19 days agoDr. Blythe Adamson - Bridging Health Economics & Oncology: EHR To Innovate & Reshape Cancer ResearchProgressPotentialAndPossibilities
29 days agoDr. Laura Aguilar, MD, Ph.D. - Diakonos Oncology - Immunotherapy For Difficult-To-Treat IndicationsProgressPotentialAndPossibilities
10 days agoProgress, Potential, and Possibilities Weekly Re-Broadcast - 4/13/25ProgressPotentialAndPossibilities
26 days agoInnoCare Pharma two thousand twenty-four Performance Report: Obutinib Rapid Volume Increase, Self ExDTnewswire
12 days agoDr. Peter Ordentlich, Ph.D. - CSO & Founder, Syndax Pharmaceuticals - Reimagining Cancer TreatmentProgressPotentialAndPossibilities
19 days agoDr. Martin Brenner, DVM, Ph.D. - CEO/CSO, iBio - Next Generation Cardiometabolic & Obesity MedicinesProgressPotentialAndPossibilities